Home › Cancro colorettale › Utah
Studi clinici su Cancro colorettale nello stato di Utah
36 studi su Cancro colorettale cercano partecipanti presso sedi nello stato di Utah.
Città nello stato di Utah
Testo ufficiale dello studio (inglese)
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
- Huntsman Cancer Institute/University of Utah, Salt Lake City
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05673148Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
- University of Utah, Salt Lake City
- Intermountain Health, Sandy City
In reclutamento
Età da 65 a 82 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05612347A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- START Mountain Region, West Valley City
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06270706A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- ALX Center 4, West Valley City
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07085091A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
- START Mountain Region, West Valley City
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2026 · NCT07659795A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
- START Mountain Region, West Valley City
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06004245A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Local Institution - 0426, Salt Lake City
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT07221357Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Huntsman Cancer Institute, University of Utah, Salt Lake City
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06445062An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
- Huntsman Cancer Institute/University of Utah, Salt Lake City
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 set 2026 · NCT06557733Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Clinical Study Site, Salt Lake City
- Clinical Study Site, Salt Lake City
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT07228832A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- START Mountain Region, West Valley City
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 4 set 2026 · NCT06400472MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
- Huntsman Cancer Institute, Salt Lake City
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 ago 2026 · NCT06586515A Study of MGC026 in Participants With Advanced Solid Tumors
- START Mountain Region, West Valley City
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 11 ago 2026 · NCT06242470A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Huntsman Cancer Institute, University of Utah, Salt Lake City
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 ago 2026 · NCT06330064A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Utah Cancer Specialists, Salt Lake City
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 lug 2026 · NCT04657068A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- Utah Cancer Specialists, Salt Lake City
- University of Utah Health Huntsman Cancer Hospital, Salt Lake City
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 lug 2026 · NCT03526835A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
- START Mountain Region, West Valley City
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 lug 2026 · NCT07318805A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- START Mountain Region, Salt Lake City
- South Texas Accelerated Research Therapeutics Mountain Region, West Valley City
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 lug 2026 · NCT06131840A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- Huntsman Cancer Institute, University of Utah, Salt Lake City
- START Mountain Region, LLC., West Valley City
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 lug 2026 · NCT06657144A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
- START Mountain Region, West Valley City
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 6 lug 2026 · NCT07300150A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Huntsman Cancer Institute, University of Utah, Salt Lake City
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 giu 2026 · NCT07458347A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- START Mountain Region, LLC, West Valley City
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 giu 2026 · NCT07503808A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
- START Mountain Region, LLC, West Valley City
In reclutamentoFase 1
Età da 18 a 99 · Tutti i sessi · Aggiornato il 16 giu 2026 · NCT07540572BBO-11818 in Adult Subjects With KRAS Mutant Cancer
- Huntsman Cancer Institute, Salt Lake City
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 giu 2026 · NCT06917079Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
- Huntsman Cancer Institute, University of Utah, Salt Lake City
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 giu 2026 · NCT06607458A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
- START Mountain Region, West Valley City
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 mag 2026 · NCT07223047Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Huntsman Cancer Institute, Salt Lake City
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 mag 2026 · NCT05379985A Study of MGC028 in Participants With Advanced Solid Tumors
- South Texas Accelerated Research Therapeutics (START) Mountain Region, West Valley City
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 27 apr 2026 · NCT06723236A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Huntsman Cancer Institute, Salt Lake City
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 apr 2026 · NCT07020221A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- START Center for Cancer Care - Mountain Region, Salt Lake City
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 27 mar 2026 · NCT06395519A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- START Mountain Region, West Valley City
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 mar 2026 · NCT06244771Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- START Mountain Region, West Valley City
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 feb 2026 · NCT07030257Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
- START, Mountain Region, West Valley City
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 feb 2026 · NCT07145255JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
- Huntsman Cancer Institute, Salt Lake City
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 gen 2026 · NCT06973564ColoCare Study - Colorectal Cancer Cohort
- Huntsman Cancer Institute, Salt Lake City
In reclutamentoStudio osservazionale
Età da 18 a 89 · Tutti i sessi · Aggiornato il 13 giu 2025 · NCT02328677Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
- Utah Cancer Specialists, Salt Lake City
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 6 mag 2025 · NCT05234177Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.